Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.09 USD | +9.99% | +1.46% | -33.23% |
Mar. 28 | Arcadia Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 28 | Transcript : Arcadia Biosciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Business Summary
Number of employees: 21
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Plant-based Food and Beverage
99.7
%
| 9 | 90.0 % | 5 | 99.7 % | -40.70% |
License
0.3
%
| 1 | 8.8 % | 0 | 0.3 % | -98.07% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
94.4
%
| 9 | 88.8 % | 5 | 94.4 % | -43.05% |
Canada
5.5
%
| 0 | 1.9 % | 0 | 5.5 % | +50.00% |
India
0.1
%
| 0 | 0.1 % | 0 | 0.1 % | 0.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stanley Jacot
CEO | Chief Executive Officer | 54 | 22-02-01 |
Thomas Schaefer
DFI | Director of Finance/CFO | 48 | 20-06-30 |
Kevin Comcowich
CHM | Chairman | 55 | 16-10-31 |
Brett Michel
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Amy Yoder
BRD | Director/Board Member | 56 | 17-08-09 |
Gregory Waller
BRD | Director/Board Member | 74 | 17-06-12 |
Kevin Comcowich
CHM | Chairman | 55 | 16-10-31 |
Lilian S. Murray
BRD | Director/Board Member | 65 | 18-05-31 |
Albert Bolles
BRD | Director/Board Member | 66 | 18-05-15 |
Debbie Carosella
BRD | Director/Board Member | 67 | 21-02-21 |
Stanley Jacot
CEO | Chief Executive Officer | 54 | 22-02-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,362,840 | 1,327,434 ( 97.40 %) | 0 | 97.40 % |
Company contact information
Arcadia Biosciences, Inc.
5950 Sherry Lane Suite 215
75225, Dallas
+214 974 8921
http://www.arcadiabio.comSales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.23% | 2.59M | |
-.--% | 11.13B | |
-7.28% | 7.21B | |
+7.47% | 6.84B | |
-3.91% | 5.92B | |
-6.14% | 5.6B | |
-10.44% | 5.57B | |
+31.35% | 5.14B | |
-13.45% | 4.56B | |
+17.77% | 4.4B |
- Stock Market
- Equities
- RKDA Stock
- Company Arcadia Biosciences, Inc.